(CANTA) Cantargia - Performance -37.4% in 12m
CANTA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-88.04%
#167 in Peer-Group
Rel. Strength
14.04%
#6631 in Stock-Universe
Total Return 12m
-37.44%
#110 in Peer-Group
Total Return 5y
-86.23%
#102 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 2.74 |
| High / Low | SEK |
|---|---|
| 52 Week High | 4.41 SEK |
| 52 Week Low | 1.03 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 87.94 |
| Buy/Sell Signal +-5 | 0.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CANTA (-37.4%) vs XBI (-11.5%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.2% | 52% | 69.3% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
0.1% | -11.2% | 153% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.77% | -8.07% | 32% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
3.7% | -8.41% | -1.43% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.34% | 26.2% | -7.5% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
3.19% | 31.5% | -17% | 26.5 | 23.9 | 0.89 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.55% | 45.2% | -10.6% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.42% | 27.7% | 15% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: CANTA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CANTA
| Total Return (including Dividends) | CANTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 132.17% | 4.38% | 5.36% |
| 3 Months | 70.50% | 14.26% | 22.49% |
| 12 Months | -37.44% | -11.53% | 14.97% |
| 5 Years | -86.23% | -28.04% | 107.82% |
| Trend Stabilty (consistency of price movement) | CANTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 49.2% | 84.9% | 92.2% |
| 3 Months | -43.8% | 79.5% | 97.6% |
| 12 Months | -88.5% | -86.5% | 48.2% |
| 5 Years | -92.6% | -51.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th98.50 | 122.44% | 120.37% |
| 3 Month | %th86.50 | 53.43% | 42.82% |
| 12 Month | %th45.50 | -29.29% | -45.59% |
| 5 Years | %th50.00 | -80.87% | -93.37% |
FAQs
Does Cantargia (CANTA) outperform the market?
No,
over the last 12 months CANTA made -37.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.53%.
Over the last 3 months CANTA made 70.50%, while XBI made 14.26%.
Performance Comparison CANTA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CANTA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 117.1% | 126.8% | 44.1% | -52% |
| US NASDAQ 100 | QQQ | 116.5% | 126% | 41.6% | -55% |
| German DAX 40 | DAX | 117.7% | 128% | 33.9% | -69% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 116.3% | 125.5% | 39.7% | -57% |
| Hongkong Hang Seng | HSI | 116.7% | 126.5% | 23.2% | -74% |
| India NIFTY 50 | INDA | 118.5% | 130.9% | 41.6% | -33% |
| Brasil Bovespa | EWZ | 120.3% | 136.6% | 34.1% | -39% |
CANTA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 117.6% | 129.3% | 40.2% | -63% |
| Consumer Discretionary | XLY | 117.5% | 126.4% | 52.1% | -56% |
| Consumer Staples | XLP | 117.7% | 130.9% | 43.3% | -43% |
| Energy | XLE | 121.3% | 133.8% | 55.4% | -33% |
| Financial | XLF | 117.1% | 127.2% | 44.4% | -61% |
| Health Care | XLV | 120.3% | 132.8% | 55.5% | -29% |
| Industrial | XLI | 116.9% | 125.3% | 40.4% | -60% |
| Materials | XLB | 119.2% | 128% | 47% | -39% |
| Real Estate | XLRE | 117.1% | 131.3% | 47.3% | -44% |
| Technology | XLK | 115.8% | 124% | 37.9% | -55% |
| Utilities | XLU | 116.2% | 127.5% | 42.7% | -61% |
| Aerospace & Defense | XAR | 112.9% | 119% | 25.6% | -92% |
| Biotech | XBI | 118.6% | 127.8% | 53.5% | -26% |
| Homebuilder | XHB | 121% | 123.2% | 57.5% | -28% |
| Retail | XRT | 118.5% | 127.5% | 48.5% | -43% |
CANTA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 119.5% | 140% | 55.2% | -32% |
| Natural Gas | UNG | 111.6% | 144.5% | 59.4% | -50% |
| Gold | GLD | 118% | 132.8% | 27% | -74% |
| Silver | SLV | 119% | 128.1% | 25.4% | -65% |
| Copper | CPER | 117.4% | 118% | 21.5% | -68% |
CANTA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 118.4% | 133.4% | 49.8% | -33% |
| iShares High Yield Corp. Bond | HYG | 117.5% | 130.8% | 45.2% | -46% |